Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
Arcus Biosciences (RCUS) Stock Price & Analysis
302 Followers
RCUS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.70 - $36.13
Previous Close$22.03
Volume4.56M
Average Volume (3M)1.03M
Market Cap
$1.61B
Enterprise Value$656.52M
Total Cash (Recent Filing)$954.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.7
Beta1.27
Next Earnings
Aug 03, 2023EPS Estimate
-$1.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.85
Shares Outstanding73,105,580
10 Day Avg. Volume1,266,446
30 Day Avg. Volume1,031,715
Standard Deviation0.24
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.24
Price to Sales (P/S)64.42
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.52
Enterprise Value/Gross Profit5.86
Enterprise Value/Ebitda-2.29
Forecast
1Y Price Target
$45.00Price Target Upside104.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Arcus Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCUS FAQ
What was Arcus Biosciences Inc’s price range in the past 12 months?
Arcus Biosciences Inc lowest stock price was $15.70 and its highest was $36.13 in the past 12 months.
What is Arcus Biosciences Inc’s market cap?
Currently, no data Available
When is Arcus Biosciences Inc’s upcoming earnings report date?
Arcus Biosciences Inc’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
How were Arcus Biosciences Inc’s earnings last quarter?
Arcus Biosciences Inc released its earnings results on May 09, 2023. The company reported -$1.09 earnings per share for the quarter, beating the consensus estimate of -$1.164 by $0.074.
Is Arcus Biosciences Inc overvalued?
According to Wall Street analysts Arcus Biosciences Inc’s price is currently Undervalued.
Does Arcus Biosciences Inc pay dividends?
Arcus Biosciences Inc does not currently pay dividends.
What is Arcus Biosciences Inc’s EPS estimate?
Arcus Biosciences Inc’s EPS estimate is -$1.15.
How many shares outstanding does Arcus Biosciences Inc have?
Arcus Biosciences Inc has 73,105,580 shares outstanding.
What happened to Arcus Biosciences Inc’s price movement after its last earnings report?
Arcus Biosciences Inc reported an EPS of -$1.09 in its last earnings report, beating expectations of -$1.164. Following the earnings report the stock price went down -3.041%.
Which hedge fund is a major shareholder of Arcus Biosciences Inc?
Among the largest hedge funds holding Arcus Biosciences Inc’s share is Invus Financial Advisors, LLC. It holds Arcus Biosciences Inc’s shares valued at 29M.
---
Arcus Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$45.00 (104.27% Upside)
$45.00 (104.27% Upside)
Blogger Sentiment
Bullish
RCUS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $146.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.04%
12-Months-Change
Fundamentals
Return on Equity
-39.96%
Trailing 12-Months
Asset Growth
-18.75%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arcus Biosciences Inc
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
---
Top 5 ETFs holding RCUS
Vanguard Health Care ETF
$2.70M
Fidelity MSCI Health Care Index ETF
$413.30K
Loncar Cancer Immunotherapy ETF
$285.03K
Up to five ETFs with an Outperform Smart Score that hold RCUS. The ETFs are listed according to market value of RCUS within the ETF
---
Ultragenyx Pharmaceutical
―
ACADIA Pharmaceuticals
―
BioCryst
―
SAGE Therapeutics
―
Insmed
―
---